Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23436835.
- Also identified by DOI 10.2214/AJR.12.9363 and PMC identifier 3603700.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this article, we review the role of imaging in cancer of unknown primary site (CUP) diagnosis and management and the utility of immunohistochemistry, serum tumor markers, and molecular profiling in the optimized care of CUP patients. With advances in imaging, pathology, and molecular medicine, the diagnosis and management of CUP have evolved into more personalized and site-specific therapies. A multidisciplinary integrated approach among oncologists, pathologists, and radiologists is extremely important.
Medical subject headings
- Diagnostic Imaging
- Image Enhancement
- Neoplasms, Unknown Primary
- Pathology, Molecular